fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Gout drug shows preliminary efficacy with hospitalized COVID-19 patients

Written by | 18 Feb 2021

Article written by Bruce Sylvester Colchicine, a gout treatment, appears to reduce the need for oxygen therapy in COVID-19 patients, researchers reported on Feb. 4, 2021 in the… read more.

Ivermectin mass treatment in perspective

Written by | 17 Feb 2021

Interview and article by Christine Clark. Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors… read more.

The Wits Vaccines and Infectious Diseases Analytics Research Unit, which runs the ChAdOx1 nCoV-19 vaccine trial in South Africa, has announced results

Written by | 16 Feb 2021

In an analysis, submitted as a pre-print prior to peer-review publication, a two-dose regimen of the ChAdOx1 nCoV-19 vaccine provides minimal protection against mild-moderate COVID-19 infection from the… read more.

Ivermectin dosing and distribution for mass treatment

Written by | 16 Feb 2021

Interview and article by Christine Clark. Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and… read more.

Raised mortality from cardiac arrest in people with COVID-19

Written by | 15 Feb 2021

Sudden cardiac arrest is more often fatal in people with COVID-19, a new study shows. Those responsible for the research see the results as a wake-up call for… read more.

Results of using ivermectin for mass treatment

Written by | 15 Feb 2021

Interview and article by Christine Clark. Mature, real world data on systematic mass treatment of covid-19 with ivermectin show a sharp fall in excess deaths. IMI interviewed Dr… read more.

COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials

Written by | 11 Feb 2021

The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca is… read more.

Heparin targets coronavirus spike protein, research shows

Written by | 10 Feb 2021

An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the… read more.

Heart disease likely to be impacted by COVID-19 for years to come

Written by | 7 Feb 2021

Heart disease remains the leading cause of death worldwide, according to the American Heart Association’s Heart Disease and Stroke Statistics — 2021 Update,

The impact of covid-19 on lung cancer care

Written by | 4 Feb 2021

Interview and article by Christine Clark. Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic… read more.

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.

Link between gut microbes, diet and illnesses

Written by | 30 Jan 2021

Diets rich in healthy and plant-based foods encourages the presence of gut microbes that are linked to a lower risk of common illnesses including heart disease, research has… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.